Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Cinder Invest in connection with an investment in Stureplansgruppen
Mandate

Vinge advises Cinder Invest in connection with an investment in Stureplansgruppen

March 19, 2021 Environmental Law M&A

Vinge is advising Cinder Invest in connection with their investment in Stureplansgruppen. The investment provides Stureplansgruppen with the preconditions to overcome the pandemic, to develop existing operations and to continue to create new guest experiences. Cinder Invest will own 20 per cent.

Cinder Invest is a joint venture between AFA, AMF, FAM together with the Wallenberg Foundations, the Fourth Swedish National Pension Fund and SEB. Cinder Invest will invest in viable Swedish companies in order to help them to overcome the adverse economic consequences of Covid-19.

Vinge's team primarily consisted of, among others, Johan Larsson, Ellinor Wargenbrant, Niclas Winnberg and Amanda Steen.

 

 

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026